Sumithira Vasu, MBBS

Trials

Studies that name Sumithira Vasu, MBBS as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 11:04 UTC. Open this list on ClinicalTrials.gov

• Ph1
  NCT04220684 · Trial Testing Safety of IL-21 NK Cells for Induction of R/R AML

  Sumithira Vasu · completed · Allogeneic Stem Cell Transplant Recipient, Blasts 10 Percent or More of Bone Marrow Nucleated Cells, Recurrent Acute Myeloid Leukemia · principal investigator
• Early Ph1
  NCT03665675 · Donor Virus-Specific CMV or AdV CTL to Treat CMV or AdV Reactivation or Disease After Solid Organ or HCT

  Sumithira Vasu · recruiting · Allogeneic Hematopoietic Stem Cell Transplantation Recipient, Cytomegalovirus, Donor · principal investigator
• Ph1/Ph2
  NCT03537599 · Daratumumab and Donor Lymphocyte Infusion in Treating Participants With Relapsed Acute Myeloid Leukemia After Stem Cell Transplant

  Sumithira Vasu · terminated · Minimal Residual Disease, Recurrent Acute Myeloid Leukemia With Myelodysplasia-Related Changes, Recurrent Adult Acute Myeloid Leukemia · principal investigator
• Ph1
  NCT02316964 · Decitabine, Donor Natural Killer Cells, and Aldesleukin in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia

  Sumithira Vasu · completed · Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Del(5q), Adult Acute Myeloid Leukemia With Inv(16)(p13;q22) · principal investigator

Grants

NIH projects from RePORTER, fetched 2026-11-12 11:04 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.

No NIH project could be tied to this name by a shared trial or a matching institution.